Figures & data
Table 1 Nutritional recall information placebo GPLC
Table 2 Exercise training volume placebo GPLC
Figure 1 Peak power (PP) determined during repeated cycling sprints with Placebo (dotted columns) and with GPLC (darkened columns). Note: Significant condition main effect (p < 0.01) and interaction effect (p < 0.05). Significant paired time contrasts for sprints 3, 4, and 5 (p < 0.05). Values are mean ± SD. * denotes statistically significant difference between conditions (p < 0.05)
![](/cms/asset/63c47e91-b16c-4545-9ea4-a13a5bbcbb1e/rssn_a_12131434_f0001_oc.jpg)
Figure 2 Mean power (MP) determined during repeated cycling sprints with Placebo (dotted columns) and with GPLC (darkened columns). Note: Significant interaction effect (p < 0.05). Significant paired time contrasts for sprints 4 and 5 (p < 0.05). Values are mean ± SD. * denotes statistically significant difference between conditions (p < 0.05)
![](/cms/asset/d6be3065-4ab9-40b7-b160-64e937ab6f41/rssn_a_12131434_f0002_oc.jpg)
Figure 3 Decrement in power output (DEC) determined during repeated cycling sprints with Placebo (dotted columns) and with GPLC (darkened columns). Note: No significant main condition or interaction effects (p > 0.05). Significant paired time contrast for sprint 5 (p < 0.05). Values are mean ± SD
![](/cms/asset/290888b4-5b0a-420d-b2d7-7464931e21d5/rssn_a_12131434_f0003_oc.jpg)
Figure 4 Lactate (PP) assessed during at rest and 4 min and 14 min following repeated cycling sprints with Placebo (dotted columns) and with GPLC (darkened columns). Note: Significant condition main effect (p < 0.05). Significant paired time contrast for 14 min post sprints (p < 0.05) but not 4 min post sprint (p = 0.09). * denotes statistically significant difference between conditions (p < 0.05)
![](/cms/asset/95c8210f-d606-4217-bdd3-dd03230cd9f0/rssn_a_12131434_f0004_oc.jpg)